pyrazines has been researched along with chiniofon in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adomat, H; Batey, RA; Chen, C; Cloos, J; Franke, NE; Guns, E; Jamal, N; Jansen, G; Kay, LE; Li, X; Li, ZH; Mao, X; Messner, H; Navon, A; Religa, TL; Rose, DR; Schimmer, AD; Sprangers, R; Trudel, S; Verbrugge, SE; Wang, X; Wood, TE; Zhang, Y | 1 |
| Kay, LE; Ruschak, AM; Schimmer, AD; Slassi, M | 1 |
1 review(s) available for pyrazines and chiniofon
| Article | Year |
|---|---|
Novel proteasome inhibitors to overcome bortezomib resistance.
Topics: Allosteric Site; Animals; Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Cell Line, Tumor; Chloroquine; Clioquinol; Drug Resistance, Neoplasm; Humans; Hydroxyquinolines; Lactones; Neoplasms; Oligopeptides; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Pyrroles; Threonine; Ubiquitinated Proteins; Ubiquitination | 2011 |
1 other study(ies) available for pyrazines and chiniofon
| Article | Year |
|---|---|
Effect of noncompetitive proteasome inhibition on bortezomib resistance.
Topics: Animals; Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Humans; Hydroxyquinolines; Immunoblotting; Inhibitory Concentration 50; Male; Mice; Mice, Inbred NOD; Mice, SCID; Multiple Myeloma; NF-kappa B; Protease Inhibitors; Proteasome Inhibitors; Pyrazines; Transplantation, Heterologous | 2010 |